{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:45:02Z","timestamp":1791229502814,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1195643"],"award-info":[{"award-number":["1195643"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.psychres.2024.116334","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T07:54:19Z","timestamp":1734681259000},"page":"116334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Safety outcomes of ketamine for treatment-resistant depression in clinical settings and development of the ketamine side effect tool-revised (KSET-R)"],"prefix":"10.1016","volume":"344","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2976-822X","authenticated-orcid":false,"given":"Adam","family":"Bayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9733-0397","authenticated-orcid":false,"given":"Thanh Vinh","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita","family":"Barreiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4385-0518","authenticated-orcid":false,"given":"Clara","family":"Massaneda-Tuneu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7918-3782","authenticated-orcid":false,"given":"Vanessa","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5939-1339","authenticated-orcid":false,"given":"Nicollette","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Glozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Beesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f2nica","family":"G\u00e1lvez-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donel","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3267-0554","authenticated-orcid":false,"given":"Colleen","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.psychres.2024.116334_bib0001","doi-asserted-by":"crossref","DOI":"10.52965\/001c.38247","article-title":"Ketamine-induced cystitis: a comprehensive review of the urologic effects of this psychoactive drug","volume":"10","author":"Anderson","year":"2022","journal-title":"Health Psychol. Res."},{"issue":"11","key":"10.1016\/j.psychres.2024.116334_bib30","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1177\/0004867419866510","article-title":"Considerations for use of ketamine to treat depression in Australia and New Zealand","volume":"53","author":"Bayes","year":"2019","journal-title":"Aust. N Z J. Psychiat"},{"issue":"12","key":"10.1016\/j.psychres.2024.116334_bib0002","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1177\/00048674211039166","article-title":"Ketamine treatment for depression: a model of care","volume":"55","author":"Bayes","year":"2021","journal-title":"Aust. N Z J. Psychiat."},{"issue":"4","key":"10.1016\/j.psychres.2024.116334_bib0004","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2024.116334_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brs.2007.08.005","article-title":"Subjective evaluation of the therapeutic and cognitive effects of electroconvulsive therapy","volume":"1","author":"Berman","year":"2008","journal-title":"Brain Stimul."},{"issue":"1","key":"10.1016\/j.psychres.2024.116334_bib0006","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the Clinician-administered dissociative states scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J. Trauma. Stress."},{"issue":"1","key":"10.1016\/j.psychres.2024.116334_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2044-8260.1982.tb01421.x","article-title":"The cognitive failures questionnaire (CFQ) and its correlates","volume":"21","author":"Broadbent","year":"1982","journal-title":"Br. J. Clin. Psychol."},{"issue":"10","key":"10.1016\/j.psychres.2024.116334_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/00048674241242315","article-title":"Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand","volume":"58","author":"Carroll","year":"2024","journal-title":"Aust. N Z J. Psychiat."},{"issue":"4","key":"10.1016\/j.psychres.2024.116334_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0269881118760660","article-title":"Repeated intranasal ketamine for treatment-resistant depression\u2013the way to go? Results from a pilot randomised controlled trial","volume":"32","author":"G\u00e1lvez","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.psychres.2024.116334_bib0009","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jagp.2017.06.007","article-title":"Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression","volume":"25","author":"George","year":"2017","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2024.116334_bib0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.eururo.2011.10.004","article-title":"The bladder pain\/interstitial cystitis symptom score: development, validation, and identification of a cut score","volume":"61","author":"Humphrey","year":"2012","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.psychres.2024.116334_bib0011","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"8","key":"10.1016\/j.psychres.2024.116334_bib38","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/pm\/pnv112","article-title":"The effects of long-term ketamine treatment on cognitive function in complex regional pain syndrome: a preliminary study","volume":"17","author":"Kim","year":"2016","journal-title":"Pain Med."},{"issue":"1","key":"10.1016\/j.psychres.2024.116334_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/acps.12572","article-title":"Placebo\u2010controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression","volume":"134","author":"Loo","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.psychres.2024.116334_bib0012","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1192\/bjp.2023.79","article-title":"Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial","volume":"223","author":"Loo","year":"2023","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2024.116334_bib33","first-page":"7","article-title":"The Clinical Alliance and Research in Electroconvulsive Therapy Network: an Australian initiative for improving service delivery of electroconvulsive therapy","volume":"34","author":"Martin","year":"2018","journal-title":"JECT"},{"issue":"3","key":"10.1016\/j.psychres.2024.116334_bib0014","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/da.22988","article-title":"Neurocognitive effects of transcranial direct current stimulation (tDCS) in unipolar and bipolar depression: findings from an international randomized controlled trial","volume":"37","author":"McClintock","year":"2020","journal-title":"Depress. Anxiety"},{"issue":"4","key":"10.1016\/j.psychres.2024.116334_bib0015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116334_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fpsyt.2014.00149","article-title":"Long-term heavy ketamine use is associated with spatial memory impairment and altered hippocampal activation","volume":"5","author":"Morgan","year":"2014","journal-title":"Front. Psychiatry."},{"issue":"10","key":"10.1016\/j.psychres.2024.116334_bib0016","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116334_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102127","article-title":"Ketamine for the treatment of major depression: a systematic review and meta-analysis","volume":"62","author":"Nikolin","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.psychres.2024.116334_bib35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"6","key":"10.1016\/j.psychres.2024.116334_bib0019","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled Study","volume":"176","author":"Popova","year":"2019","journal-title":"Am. Jo. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2024.116334_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1098-3597(01)90074-2","article-title":"Evaluation of abnormal liver tests","volume":"3","author":"Rochling","year":"2001","journal-title":"Clin. Cornerstone"},{"issue":"5","key":"10.1016\/j.psychres.2024.116334_bib0021","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.urology.2007.01.038","article-title":"Ketamine-associated ulcerative cystitis: a new clinical entity","volume":"69","author":"Shahani","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.psychres.2024.116334_bib0022","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jad.2020.01.120","article-title":"Development of the Ketamine Side Effect Tool (KSET)","volume":"266","author":"Short","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2024.116334_bib0023","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2024.116334_bib0008","unstructured":"ClinicalTrials.gov. 2024. Clinicaltrials.gov. https:\/\/clinicaltrials.gov\/policy\/results-definitions#adverseEventInformation."},{"key":"10.1016\/j.psychres.2024.116334_bib0024","unstructured":"Therapeutic Good Administration (2021). https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar-esketamine-hydrochloride-210507-pi.pdf."},{"issue":"10","key":"10.1016\/j.psychres.2024.116334_bib0025","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1442-2042.2009.02361.x","article-title":"Ketamine-associated bladder dysfunction","volume":"16","author":"Tsai","year":"2009","journal-title":"Int. J. Urol."},{"issue":"1","key":"10.1016\/j.psychres.2024.116334_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-238135","article-title":"Oral S-ketamine effective after deep brain stimulation in severe treatment-resistant depression and extensive comorbidities","volume":"14","author":"Veraart","year":"2021","journal-title":"BMJ Case Rep."},{"issue":"3","key":"10.1016\/j.psychres.2024.116334_bib36","doi-asserted-by":"crossref","first-page":"19m12891","DOI":"10.4088\/JCP.19m12891","article-title":"Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)","volume":"81","author":"Wajs","year":"2020","journal-title":"J. Clin. Psychiatry."},{"issue":"3","key":"10.1016\/j.psychres.2024.116334_bib0027","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jamapsychiatry.2023.4945","article-title":"The rapidly shifting ketamine landscape in the US","volume":"81","author":"Wilkinson","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2024.116334_bib0028","first-page":"e36742","article-title":"Comparing the safety and effectiveness of ketamine versus benzodiazepine\/opioid combination for procedural sedation in emergency medicine: a comprehensive review and meta-analysis","volume":"15","author":"Zaki","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.psychres.2024.116334_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109305","article-title":"Ketamine and its metabolites: potential as novel treatments for depression","volume":"222","author":"Zhang","year":"2023","journal-title":"Neuropharmacology"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517812400619X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517812400619X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T15:38:21Z","timestamp":1737301101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517812400619X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":35,"alternative-id":["S016517812400619X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2024.116334","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety outcomes of ketamine for treatment-resistant depression in clinical settings and development of the ketamine side effect tool-revised (KSET-R)","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2024.116334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116334"}}